|
||||
Home| Postal News | Your Rights | Editorials | Resources| Links | About | What's New | Sitemap | Search| Letter to Editor
Postal security plan would evacuate employees, close mail facilities-4/3/03 Diagram of contamination at the Brentwood Mail Processing Distribution Center Diagram of polymerase chain reaction (PCR) technology Biohazard Detection Systems
|
||||
|
||||
USPS suspends Biohazard Detection SystemTime Out Called Non-determinant test results temporarily halt BDS rollout Some tests are neither positive nor negative — they’re inconclusive. For the Biohazard Detection System (BDS), an inconclusive test is called a “non-determinant.” Recently, we’ve experienced more non-determinants than we think we should at two sites where new systems are being installed. As a result, national BDS deployment is being temporarily halted so we can address this issue. A non-determinant doesn’t indicate a threat is suspected, it simply means the test result is inconclusive. During the pre-production phase, 15 pilot sites around the country were chosen for their varied metropolitan and rural settings. These sites allowed us to calibrate the system and establish a baseline for future reference. Compared to that baseline, we’re seeing an increase in non-determinate results on several machines. Our objective throughout this whole process has been to provide a scientifically valid approach to detecting threats in the mail. The Biohazard Detection System does that. And we’re taking every step necessary to make sure the BDS is working properly before it is rolled out nationwide. We expect to resume deployment soon. USPS newslink 4/28/2004 |
||||
Cepheid drops
on worries over postal detection contract
(source: CBS Marketwatch) April 29, 2004-Cepheid shares fell as much as 35 percent Thursday after the company said that the U.S. Postal Service is delaying temporarily deployment of the company's biohazard detection system. Sunnyvale, Calif.-based Cepheid (CPHD), which makes systems to detect infectious disease agents and environmental contaminants, won a role in a Postal Service contract after a series of anthrax-laced envelopes were sent via the mail in the months after Sept. 11, 2001. The Postal Service initially installed detection systems in 15 pilot sites. The delay in further installing the detection system comes after a number of sorting lines began to see an increase in the number of tests coming up as "non-determinant." Cepheid Developer of BDS Comments on USPS Announcement (4/29/04) |
||||
November 10, 2003
-Postal Service spokesman Bob Anderson said the agency plans in
March to install new biohazard detection systems at 282 major
processing and distribution centers across the country. The new
systems will scan mail that is collected from drop boxes for
possible contamination, Anderson said. All mail destined for
federal agencies in Washington will continue to be irradiated.
more at Govexec. com |
||||
April 8, 2003-(Dow Jones)
USPS To Test Biohazard Detection Systems For Anthrax -USPS said
it will test a Biohazard Detection System to detect anthrax in 14 postal
facilities across the country. Mail processing and distribution centers in
Dulles, Va.; southern Maryland (Capitol Heights); Albany, N.Y.; Kilmer, N.J.; Manasota, Fla.;
St. Petersburg, Fla.; Tampa, Fla.; Midland, Texas; Los Angeles Ca.;; Tacoma,
Wash.; Rockford, Ill.; Lancaster, Pa.; Pittsburgh, Pa.; and Cleveland, OH.
will test the device for 30 days.. Northrop Grumman Corp.'s Security Systems LLC unit
will provide the Biohazard Detection Systems for the 30-day tests. The
systems is designed to detect anthrax spores and other biological agents by
collecting and analyzing air samples from mail-sorters. Cepheid Inc. , Smiths
Detection, a unit of Smiths Group PLC , and Sceptor Industries worked with
Northrop on the project.
Other tidbits gathered from various news sources on the internet • The companies, led by Northrop Grumman Corp., are planning to install desk-size devices in regional mail sorting centers. The devices continually will sample and test air on automated lines that sort thousands of letters an hour. Sceptor's part of the system, called SpinCon (pictured at left) , can extract minute contaminants from the air. • The automated system includes a tube that sucks air from the point where letters are slightly bent to be read by the mail sorting machines. It was at that point, according to postal officials, that anthrax spores were released in the New Jersey and Washington mail-sorting centers. Sceptor's air sampler will draw those air samples through a spinning membrane of chemically enhanced water that wrings out minute contaminants. The water is then bottled for testing. Those tests are done with technology from another small company, Cepheid Inc. of Sunnyvale, Calif. The company's GeneXpert (pictured at right) testing system detects trace levels of DNA. • The goal is to have machines in 283 mail processing plants. The system is fully automated and will shut down operations if a biological agent is detected. The purpose of the system is to protect customers, employees, and the system. A Stand-up Talk will be sent to the field for dissemination. |
||||
WASHINGTON -- The Postal Service, still
feeling the effects of the anthrax-by-mail attacks 18 months ago, said today
it will test a new anthrax detection system in mail sorting sites around the
country, including in Pittsburgh. |
||||
SUNNYVALE, Calif.,/PRNewswire-March 26, 2003 -Cepheid (Nasdaq: CPHD), announced that Northrop Grumman has issued
the following statement with regard to the continuing program for development
of a bio-agent detection system for the United States Postal Service: The Northrop Grumman system uses polymerase chain reaction (PCR) technology, developed by Cepheid (Nasdaq: CPHD), that can identify anthrax and other bio-threats that could potentially be sent through the mail. Negotiations continue between Northrop Grumman and the USPS on all terms of the production contract, including indemnification, to deploy the system at postal facilities nationwide. Northrop Grumman Corporation is a $25
billion global defense company, headquartered in Los Angeles, Calif. Northrop
Grumman provides technologically advanced, innovative products, services and
solutions in systems integration, defense electronics, information
technology, advanced aircraft, shipbuilding and space technology. With
approximately 120,000 employees and operations in all 50 states and 25
countries, Northrop Grumman serves U.S. and international military,
government and commercial customers." |
||||
Northrop Grumman Team Receives United States Postal Service Contract to Expand Testing of Bio-Agent Detection SystemSunnyvale, CA, December 13, 2002 …/PRNewswire Cepheid (NASDAQ: CPHD), today announced that the Northrop Grumman Corporation’s Security Systems LLC unit has announced receipt of a contract award from the U.S. Postal Service (USPS) to expand and continue testing of the Bio-Agent Detection System (BDS) being developed by a Northrop Grumman-led team, which includes Cepheid. Under the pre-production contract announced by Northrop, systems will be installed and tested at 14 USPS facilities. This will enable the postal service to validate performance of the final BDS design, which successfully completed a pilot program earlier this year. As indicated in the release by Northrop, the BDS may eventually be deployed at postal service facilities throughout the country, pending award of a full production contract. The BDS incorporates Cepheid’s GeneXpert® modules as its detection and identification system and utilizes Cepheid’s patented test cartridges. Cepheid and Applied Biosystems (NYSE: ABI) an Applera Corporation business, previously announced a collaboration to develop and sell reagents designed to detect biothreat agents to be used in the cartridges. “We are delighted to be a part of the team that has developed a fully integrated solution for the USPS,” commented Tom Gutshall, chairman of Cepheid. “The selection of the GeneXpert system for the BDS further validates the unique capabilities of Cepheid’s technology and its potential applicability in the commercial marketplace.”
|
||||
Polymerase Chain Reaction or PCR (source APWU)
A telecon took place on 6/18/02 between the Postal Unions
and area and Hdtr Postal management updating the matter of detection systems.
|
||||
polymerase chain reaction (PCR) technology |
||||
Polymerase Chain Reaction
(PCR) The elegant technique of PCR, by which fragments of DNA can be made to replicate very rapidly, is illustrated. Figure Legend: Polymerase chain reaction (PCR), is a common method of creating copies of specific fragments of DNA. PCR rapidly amplifies a single DNA molecule into many billions of molecules. In one application of the technology, small samples of DNA, such as those found in a strand of hair at a crime scene, can produce sufficient copies to carry out forensic tests. (source National Health Museum) |
||||
|